One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone TumorsA Randomized Clinical Trial
doi : 10.1001/jamaoncol.2021.6628
March 2022, Vol 8, No. 3, Pages 326-487
Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia
Shawn H. R. Lee, MBBS; Federico Antillon-Klussmann, MD; Deqing Pei, MS; et al.
Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus–Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy
C. Jillian Tsai, MD, PhD; Sean M. McBride, MD, MPH; Nadeem Riaz, MD, MS; et al.
Comparison Between the 2021 USPSTF Lung Cancer Screening Criteria and Other Lung Cancer Screening Criteria for Racial Disparity in Eligibility
Chan Yeu Pu, MD, MS; Christine M. Lusk, MPH; Christine Neslund-Dudas, PhD; et al.
Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis
Laurent Dercle, MD, PhD; Binsheng Zhao, DSC; Mithat Gönen, PhD; et al.
Association of Daily Sitting Time and Leisure-Time Physical Activity With Survival Among US Cancer Survivors
Chao Cao, MPH; Christine M. Friedenreich, PhD; Lin Yang, PhD
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors
Guru Subramanian Guru Murthy, MD, MS; Soyoung Kim, PhD; Zhen-Huan Hu, MPH; et al.
Development and Assessment of a Predictive Score for Vertebral Compression Fracture After Stereotactic Body Radiation Therapy for Spinal Metastases
Roman O. Kowalchuk, MD; Benjamin A. Johnson-Tesch, MD; Joseph T. Marion, MD; et al.
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019A Systematic Analysis for the Global Burden of Disease Study 2019
Global Burden of Disease 2019 Cancer Collaboration
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes
Breast Cancer Association Consortium
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate CancerA Patient-Level Data Analysis of 3 Cohorts
Amar U. Kishan, MD; Alison Steigler, BMath; James W. Denham, MD; et al.
Geospatial Disparities in the Treatment of Curable Breast Cancer Across the US
Michael J. Hassett, MD, MPH; Angela C. Tramontano, MPH; Hajime Uno, PhD; et al.
Association of BMI With Benefit of Metformin Plus Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors in Patients With Advanced Lung AdenocarcinomaA Secondary Analysis of a Phase 2 Randomized Clinical Trial
Oscar Arrieta, MD, MSc; Zyanya Lucia Zatarain-Barrón, MD, MSc; Jenny G. Turcott, PhD; et al.
Radiofrequency Radiation and CancerA Review
David Robert Grimes, PhD
Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint InhibitorsA Review
Ananthan Sadagopan; Theodoros Michelakos, MD; Gabriella Boyiadzis; et al.
Immunotherapy for the Neoadjuvant Management of Resectable Intrathoracic CancersLet's Not Forget Radiotherapy
Joe Y. Chang, MD, PhD; Vivek Verma, MD; Ralph R. Weichselbaum, MD
Accelerated Approval Is Not Conditional ApprovalInsights From International Expedited Approval Programs
Gautam U. Mehta, MD; R. Angelo de Claro, MD; Richard Pazdur, MD
Measuring the Effect of Local Control From Radiotherapy in Patients With Pancreatic Adenocarcinoma
Nina N. Sanford, MD; Beow Y. Yeap, ScD; Theodore S. Hong, MD
Antibiotic Prophylaxis of Surgical Site Infections—A Double-edged Sword for Oncology Patients?
Valerae O. Lewis, MD; Christina L. Roland, MD, MS
Genetic Ancestry and Childhood Acute Lymphoblastic Leukemia Subtypes and Outcomes in the Genomic Era
Karen R. Rabin, MD, PhD
Decreasing the Dose and Volume of Elective Nodal Radiotherapy in HPV-Associated Oropharyngeal CancerHow Low Can We Go?
Philip E. Schaner, MD, PhD; Ravi A. Chandra, MD, PhD
New 2021 USPSTF Lung Cancer Screening Criteria—An Opportunity to Mitigate Racial Disparity
Jonathan A. Nitz, MD; Cherie P. Erkmen, MD
Analysis of Routine Computed Tomographic Scans With Radiomics and Machine LearningOne Step Closer to Clinical Practice
Michael D. Farwell, MD; David A. Mankoff, MD, PhD
Use of Participation to Prevalence Ratio for Evaluating the Representation Status of Women in Oncology Clinical Trials
Siliang Chen, MD; Jiarui Li, MD; Meijun Shu, MD
Use of Participation to Prevalence Ratio for Evaluating the Representation Status of Women in Oncology Clinical Trials—Reply
Kristina Jenei, BSN, MSc; Daniel E. Meyers, MD, MSc; Vinay Prasad, MD
Hypofractionated Radiotherapy for Locally Advanced Non–Small Cell Lung Cancer—Does Size Matter?
Nitin Ohri, MD, MS; Maria Werner-Wasik, MD
Hypofractionated Radiotherapy for Locally Advanced Non–Small Cell Lung Cancer—Does Size Matter?—Reply
Elizabeth Zhang-Velten, MD, PhD; Puneeth Iyengar, MD, PhD; Robert D. Timmerman, MD
Is 2045 Optimistic?—Concerns Regarding Rising Vaccine Hesitancy
Erich M. Sturgis, MD, MPH; Malgorzata K. Nowakowska, BS; Jay K. Ferrell, MD
Is 2045 Optimistic?—Concerns Regarding Rising Vaccine Hesitancy—Reply
Yuehan Zhang, ScM; Carole Fakhry, MD; Gypsyamber D’Souza, PhD
Concerns About Methods Used in Modeling Study of Risk-Stratified Screening for Breast Cancer
Nora Pashayan, MD, PhD; Paul D. P. Pharoah, MBBS, PhD
Errors in the Calculation Used to Estimate Number of Overdiagnoses in Study of Risk-Stratified Screening for Breast Cancer
